CTC enumeration and characterization has predictive and prognostic implications in patients with metastatic breast cancer treated with exemestane plus the mTOR inhibitor everolimus

被引：0
|
作者：
Agelaki, Sofia [1 ,2 ]
Mavroudis, Dimitris [1 ,2 ]
Spiliotaki, Maria [2 ]
Politaki, Eleni [2 ]
Papadaki, Maria A. [2 ]
Apostolaki, Stella [2 ]
Nikolaou, Christos [1 ]
Georgoulias, Vassilis [1 ,2 ]
机构：
[1] Univ Hosp Heraklion, Iraklion, Greece
[2] Univ Crete, Sch Med, Lab Tumor Cell Biol, Rethimnon, Greece
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-13
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial
    Burris, Howard A., III
    Lebrun, Fabienne
    Rugo, Hope S.
    Beck, J. Thaddeus
    Piccart, Martine
    Neven, Patrick
    Baselga, Jose
    Petrakova, Katarina
    Hortobagyi, Gabriel N.
    Komorowski, Anna
    Chouinard, Edmond
    Young, Robyn
    Gnant, Michael
    Pritchard, Kathleen I.
    Bennett, Lee
    Ricci, Jean-Francois
    Bauly, Hounayda
    Taran, Tetiana
    Sahmoud, Tarek
    Noguchi, Shinzaburo
    CANCER, 2013, 119 (10) : 1908 - 1915
  • [32] BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine
    Isaacs, C.
    Ozguroglu, M.
    Jerusalem, G.
    Xu, B.
    Lang, I.
    O'Regan, R.
    White, M.
    Fasolo, A.
    Litton, J.
    Toi, M.
    Shen, K.
    Andre, F.
    Vuylsteke, P.
    Zhang, Y.
    Zhang, J.
    Taran, T.
    Wilks, S.
    CANCER RESEARCH, 2013, 73
  • [33] Outcomes of Everolimus plus Exemestane in ER-positive, HER2-negative Heavily Pre-treated Metastatic Breast Cancer Patients: A Real Life Multicentre Experience
    Desai, P.
    Hogg, M.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E42 - E43
  • [34] SAFETY OF COMBINED EXEMESTANE AND EVEROLIMUS IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER PATIENTS - A RETROSPECTIVE ANALYSIS
    Gilchrist, Jenny
    Todd, J.
    Kefford, R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 176 - 176
  • [35] Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life
    Cocciolone, V.
    Cannita, K.
    Tessitore, A.
    Rinaldi, L.
    Irelli, A.
    Dal Mas, A.
    Calvisi, G.
    Bafile, A.
    Alesse, E.
    Ricevuto, E.
    Ficorella, C.
    ANNALS OF ONCOLOGY, 2015, 26 : 24 - 24
  • [36] Prognostic and predictive value of circulating tumor cells in metastatic breast cancer patients treated with endocrine or chemotherapy
    Ellis, MJ
    Miller, MC
    Cristofanilli, M
    Budd, GT
    Stopeck, A
    Hayes, DF
    Doyle, GV
    Matera, J
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S7 - S7
  • [37] Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
    Jerusalem, Guy
    Fasolo, Angelica
    Dieras, Veronique
    Cardoso, Fatima
    Bergh, Jonas
    Vittori, Luc
    Zhang, Yufen
    Massacesi, Cristian
    Sahmoud, Tarek
    Gianni, Luca
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 447 - 455
  • [38] Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
    Guy Jerusalem
    Angelica Fasolo
    Veronique Dieras
    Fatima Cardoso
    Jonas Bergh
    Luc Vittori
    Yufen Zhang
    Cristian Massacesi
    Tarek Sahmoud
    Luca Gianni
    Breast Cancer Research and Treatment, 2011, 125 : 447 - 455
  • [39] evERA Breast Cancer: A phase III study of giredestrant (GDC-9545) + everolimus vs exemestane plus everolimus in patients with estrogen receptor+, HER2-locally advanced or metastatic breast cancer
    Mayer, Erica L.
    Tolaney, Sara
    Brufsky, Adam M.
    Gradishar, William
    Jhaveri, Komal
    Martin, Miguel
    Moscetti, Luca
    Vidal, Gregory
    Cortazar, Patricia
    Feldman, Merilin
    Day, Bann-mo
    Rugo, Hope
    CANCER RESEARCH, 2023, 83 (05)
  • [40] Effect of IL-15 Gene Therapy and mTOR Inhibitor Everolimus on Experimental Metastatic Breast Cancer Growth
    Zhao, Na
    Li, Xiaodan
    Qi, Feng
    Qiu, Yujie
    He, Xianghui
    Zhu, Liwei
    MOLECULAR THERAPY, 2013, 21 : S155 - S156
12345